BNKKHIGH SIGNALRISK10-K

BNKK has completely pivoted from a dietary supplement business to a cryptocurrency treasury strategy focused on the highly volatile BONK token, creating extreme concentration risk.

The company has abandoned its Safety Shot dietary supplement business and repositioned as a BONK token holder, exposing shareholders to the extreme volatility of a meme cryptocurrency. This represents a fundamental business model change with newly disclosed risks around token price fluctuations directly impacting financial results and the company's ability to meet obligations.

Comparing 2026-03-31 vs 2025-03-28View on EDGAR →
FINANCIAL ANALYSIS

Despite dramatic improvements in stockholders' equity (+1710%), cash position (+703%), and total assets (+458%), along with a return to gross profitability, the company's net losses deepened by 38% to $68.2M while interest expenses exploded by 1386%. The strong balance sheet improvements appear driven by the BONK token strategy, but the widening losses and massive interest expense increase signal underlying operational challenges that could be exacerbated by cryptocurrency volatility.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
+1710.5%
-$2.2M$35.0M

Equity base grew 1710.5% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Interest Expense
P&L
+1386.4%
$117K$1.7M

Interest expense surged 1386.4% — significant debt increase or rising rates materially impacting earnings.

Cash & Equivalents
Balance Sheet
+702.6%
$531K$4.3M

Cash position surged 702.6% — strong cash generation or capital raise providing significant financial cushion.

Total Assets
Balance Sheet
+458.3%
$7.3M$41.0M

Asset base grew 458.3% — expansion through organic growth, acquisitions, or capital deployment.

Inventory
Balance Sheet
+306.5%
$234K$949K

Inventory surged 306.5% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.

Revenue
P&L
+201.6%
$702K$2.1M

Strong top-line growth of 201.6% — accelerating demand or successful expansion into new markets.

Gross Profit
P&L
+150.6%
-$2.4M$1.2M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Current Assets
Balance Sheet
+134.2%
$2.6M$6.0M

Current assets grew 134.2% — improving short-term liquidity or inventory/receivables build.

R&D Expense
P&L
-91.1%
$272K$24K

R&D spending cut 91.1% — could signal cost discipline or concerning reduction in innovation investment.

Net Income
P&L
-38%
-$49.4M-$68.2M

Net income declined 38% — review whether driven by operations, interest costs, or non-recurring items.

LANGUAGE CHANGES
NEW — 2026-03-31
PRIOR — 2025-03-28
ADDED
Employer incorporation or organization) Identification) 18801 N.
The market value of securities held by non-affiliates was $ 31,796,306 as of June 30, 2025, based on the closing price of $11.55 for the registrant s common stock on June 30, 2025.
The SEC maintains a website (www.sec.gov) that contains these publicly filed reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including us.
Our significant risks may be summarized as follows: Risks Related to Our Business The BONK token is a highly volatile asset, and fluctuations in the price of the BONK token are likely to affect our financial results and the market price of our listed securities.
A significant decrease in the market value of our BONK token holdings could adversely affect our ability to satisfy our financial obligations.
+7 more — sign up free →
REMOVED
Employer incorporation or organization) Identification) 1061 E.
The public can read and copy any materials we file with the SEC at the SEC s Public Reference Room at 100 F Street, NE, Washington, DC 20549.
You can obtain additional information about the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.
In addition, the SEC maintains an Internet site (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including us.
In August 2023, the Company successfully completed the asset purchase of the Safety Shot Dietary Supplement from GBB Drink Lab, Inc.
+7 more — sign up free →
MORE RISK SIGNALS
CAPSHIGHCAPS underwent a major business expansion through acquisitions while experiencin...
2026-04-16
KALAHIGHKALA has undergone a dramatic business transformation with massive share dilutio...
2026-04-15
RAINHIGHRain Enhancement Technologies underwent a financial restatement revealing signif...
2026-04-15
POLAHIGHPOLA experienced severe financial deterioration with gross profit turning negati...
2026-04-15
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →